# Pomegranate Extract in Treating Patients With Rising Prostate-Specific Antigen Levels After Surgery or Radiation Therapy for Localized Prostate Cancer

> **NCT00336934** · NA · COMPLETED · sponsor: **Roll International Corporation** · enrollment: 183 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **DIETARY_SUPPLEMENT:** pomegranate juice
- **OTHER:** placebo

## Key facts

- **NCT ID:** NCT00336934
- **Lead sponsor:** Roll International Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-11
- **Primary completion:** 2010-07
- **Final completion:** 2010-12
- **Target enrollment:** 183 (ACTUAL)
- **Last updated:** 2011-08-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00336934

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00336934, "Pomegranate Extract in Treating Patients With Rising Prostate-Specific Antigen Levels After Surgery or Radiation Therapy for Localized Prostate Cancer". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00336934. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*